II. Indications
- 
                          Central Nervous System Stimulant- Caffeine is the most widely used psychoactive substance in the world
- Daly (1998) Lakartidningen 95(51-52):5878-83 [PubMed]
 
- Idiopathic Apnea of Prematurity
- 
                          Sports Performance Supplement (Ergogenic Aid)- Athletes are limited to 12-15 mcg/ml urine depending on regulatory agency (NCAA, IOC)
- Performance enhancing in endurance sports
 
- 
                          Headaches- CNS Arteriole constriction may be palliative in Acute Migraine Headache (component of Excedrin-Migraine)
- Risk of Caffeine withdrawal Headache
- High dose Caffeine may be effective in Spinal Headache
 
III. Preparations: Relative Caffeine amounts
- 10 mg/serving- Decaffeinated coffee (7 oz, 210 ml)
- Milk Chocolate (1.5 oz)
 
- 30 mg/serving- Dark Chocolate (1.5 oz)
 
- 50 mg/serving- Tea (8 oz, 240 ml)
- Caffeinated soda (12 oz, 360 ml)
- Coffee ice cream (8 oz, 240 ml)
 
- 100 mg/serving- Coffee (8 oz, 240 ml)
 
- 150 mg/serving- Espresso (2 oz, 60 ml)
 
- 250-350 mg/serving- Energy Drinks (8-16 oz, e.g. Redline, Spike, Hyde, Wired, Loud, Java Monster, Rockstar, Bang)
 
IV. Precautions
- Energy drinks contain high levels of stimulants- Combined Caffeine and Methylxanthines may exceed 500 mg total
- Higher risk of toxicity
 
- Limit daily Caffeine below maximum- Adults: 400 mg/day
- Teens: 2.5 mg/kg/day (up to 400 mg/day)
 
V. Mechanism
- Methylxanthine
- Adenosine Receptor Antagonist
- At high dose, Phosphodiesterase Inhibitor (increased 3-5 cAMP, increased intracellular Calcium)
- Stimulates Catecholamines (increased beta-1 and beta-2 Agonist activity)- Stimulates CNS and cardiac activity
- CNS Arteriole constriction
- Bronchodilator
- Diuretic
 
VI. Pharmacokinetics
- Metabolism: Zero order elimination (very slow elimination)
- Hepatic Metabolism
- High oral Bioavailability
- Oral onset of peak activity <2 hours
- Half-Life: 4-5 hours (as long as 60-100 hours in newborns)
- Volume of distribution: 0.6 to 0.7 L/kg (0.8 to 0.9 in newborns)
- Protein binding: 17%
- Concentrations- Toxicity: >35 mg/kg (esp. children)
- Lethal Dose: 10-20 grams in an adult (>100 mg/kg)
 
VII. Adverse Effects: Non-toxic Ingestion
- Anxiety
- Jitteriness
- Arrhythmia
- Insomnia
- Diuresis
VIII. Adverse Effects: Toxic Levels
- General
- Cardiopulmonary- Respiratory Depression
- Dysrhythmia (e.g. Multifocal Atrial Tachycardia)
- Hypertension
- Wide Pulse Pressure (with diastolic Hypotension)
 
- Gastrointestinal
- Neuropsychiatric
IX. Labs: Toxicity
- Consider evaluation for Unknown Ingestion
- Caffeine concentration is not typically available outside tertiary centers
- Basic Chemistry Panel
X. Management: Severe Caffeine Toxicity or Overdose
- 
                          General- Consider other ingestions
- Consider Poison Control Consultation
 
- Antidotes- Consider Activated Charcoal after recent known large ingestion
- Consider Intralipid (20% lipid emulsion) 1.5 mg/kg for refractory Hypotension or tachydysrhythmia
 
- Supportive care- ABC Management
- Vasopressors for Hypotension (e.g. Norepinephrine, Vasopressin)
- Consider Esmolol infusion for tachydysrhythmia (Exercise caution)
- Consider Benzodiazepines for Agitation
 
- 
                          Hemodialysis Indications
                          - Seizures
- refractory Hypotension or tachydysrhythmia
- Caffeine concentration at toxic levels (>100 mg/L acutely, >60 mg/L chronically)
 
- Discharge Indications- Asymptomatic at 4-6 hours after ingestion
 
XI. Resources
- FDA News: Investigation into Energy Drinks and Supplements
XII. References
- Leikin (1996) Poisoning and Toxicology Handbook, Lexicomp, Hudson, Ohio, p. 175-7
- Nordt in Herbert (2012) EM: Rap 12(8): 5
- Tomaszewski (2019) Crit Dec Emerg Med 33(12): 32
Images: Related links to external sites (from Bing)
Related Studies
| caffeine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| CAFFEINE 200 MG TABLET | Generic OTC | $0.08 each | 
